NCT06825234View on ClinicalTrials.gov

Prognostic Value of a Multidimensional Assessment for Survival in Elderly Patients With CKD 4B/5

Not yet recruitingOBSERVATIONAL
Enrollment

390

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Chronic Kidney Disease Stage 5Chronic Kidney Disease Stage 4B
Trial Locations (2)

25000

Besançon University Hospital, Besançon

37044

Tours University Hospital, Tours

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT06825234 - Prognostic Value of a Multidimensional Assessment for Survival in Elderly Patients With CKD 4B/5 | Biotech Hunter | Biotech Hunter